Irish firm snapped up by Chicago-based AbbVie in one of biggest ever pharmaceutical deals
The US drug company AbbVie is to buy Allergan, the Irish-based maker of Botox, for $63bn (£49bn), in one of the biggest deals in the global pharmaceutical industry.
Chicago-based AbbVie, which makes the world’s best-selling drug Humira, for rheumatoid arthritis and other inflammatory diseases, said it would pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. This amounts to $188.24 per share.
Continue reading...from Mergers and acquisitions | The Guardian http://bit.ly/31PZf1E
No comments:
Post a Comment